These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3297336)

  • 41. Type II collagen-induced autoimmune ear disease in mice: a preliminary report on an epitope of the type II collagen molecule that induced inner ear lesions.
    Takeda T; Sudo N; Kitano H; Yoo TJ
    Am J Otol; 1996 Jan; 17(1):69-75. PubMed ID: 8694137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular basis of type II collagen autoimmune ear diseases.
    Yoo TJ; Fujiyoshi T; Cheng KC; Krug MS; Kim NS; Lee KM; Shen T; Matsuoka H
    Ann N Y Acad Sci; 1997 Dec; 830():221-35. PubMed ID: 9616681
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral tolerance in the control of experimental models of autoimmune disease.
    Staines NA; Harper N
    Z Rheumatol; 1995; 54(3):145-54. PubMed ID: 7660685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
    Miller SD; Turley DM; Podojil JR
    Nat Rev Immunol; 2007 Sep; 7(9):665-77. PubMed ID: 17690713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmunity: attack, or defence? (The case for a primary lesion theory).
    Wilkin T
    Autoimmunity; 1989; 3(1):57-73. PubMed ID: 2491621
    [No Abstract]   [Full Text] [Related]  

  • 46. The continuous discovery of autoantigens in endocrine organ-specific autoimmunity: do they help us to understand pathogenesis?
    Fierabracci A; Bottazzo GF
    Springer Semin Immunopathol; 2002 Dec; 24(3):243-59. PubMed ID: 12503053
    [No Abstract]   [Full Text] [Related]  

  • 47. Autoimmune diseases: beyond clinical and/or immune parameters to pathogenic process.
    Ferreira CA
    Pathol Biol (Paris); 2006 Apr; 54(3):119-21. PubMed ID: 16495021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of autoantigens in the driving of autoimmune diseases.
    Roitt IM
    Immunol Ser; 1993; 59():119-29. PubMed ID: 7681695
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral tolerance.
    Komagata Y; Weiner HL
    Rev Immunogenet; 2000; 2(1):61-73. PubMed ID: 11324694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breakdown of self-tolerance and the pathogenesis of autoimmunity.
    Ring GH; Lakkis FG
    Semin Nephrol; 1999 Jan; 19(1):25-33. PubMed ID: 9952278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic lesions in T-cell tolerance and thresholds for autoimmunity.
    Liston A; Lesage S; Gray DH; Boyd RL; Goodnow CC
    Immunol Rev; 2005 Apr; 204():87-101. PubMed ID: 15790352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tolerance and autoimmunity.
    Goust JM; Tsokos G; Virella G
    Immunol Ser; 1993; 58():397-421. PubMed ID: 8424985
    [No Abstract]   [Full Text] [Related]  

  • 53. Reversing the autoimmune condition: experience with experimental autoimmune gastritis.
    Alderuccio F; Murphy K; Biondo M; Field J; Toh BH
    Int Rev Immunol; 2005; 24(1-2):135-55. PubMed ID: 15763994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycoconjugates in autoimmunity.
    Gleeson PA
    Biochim Biophys Acta; 1994 Dec; 1197(3):237-55. PubMed ID: 7819267
    [No Abstract]   [Full Text] [Related]  

  • 55. Autoimmunity of the ear.
    Yoo TJ; Ishibe T
    Concepts Immunopathol; 1987; 4():215-42. PubMed ID: 3297336
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.